Caixin
Aug 09, 2022 08:00 AM

Jiangsu Gdk Biological Technology Co.,Ltd. Posted 17.3 Million Yuan Net Loss in First Half of 2022

Jiangsu Gdk Biological Technology Co.,Ltd. (江苏金迪克生物技术股份有限公司) (688670.SH) reported a net loss of 17.3 million yuan in the first half of 2022, narrowing 25.9% year-on-year.

Meanwhile, the company posted 16.4 million yuan in revenue, down 48.9% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 248.2 million yuan in total liabilities, with a liability-to-asset ratio of 15.1%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Visa-Free Travel, U.S. Tariffs Drive Chinese Companies to Malaysia
00:00
00:00/00:00